title: [Stage V bilateral retinoblastoma at the Curie Institute. Report of 33 cases].
authors.forename: C
authors.initials: C
authors.lastname: Haye
authors.forename: L
authors.initials: L
authors.lastname: Desjardins
authors.forename: P
authors.initials: P
authors.lastname: Schlienger
authors.forename: J M
authors.initials: JM
authors.lastname: Zucker
authors.forename: M
authors.initials: M
authors.lastname: Laurent
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects; D003131:Combined Modality Therapy; D005134:Eye Neoplasms / Q000473:pathology / Q000628:therapy*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007223:Infant; D008297:Male; D009367:Neoplasm Staging; D012175:Retinoblastoma / Q000473:pathology / Q000628:therapy*; D012189:Retrospective Studies
chemical_list: D000970:Antineoplastic Agents
vernacular_title: Rétinoblastomes bilatéraux stade V à l'Institut Curie. A propos de 33 cas.